Annual report pursuant to Section 13 and 15(d)

Acquisitions, Investments, and Licenses - Schedule of EirGen Purchase Price Allocation (Details)

v3.6.0.2
Acquisitions, Investments, and Licenses - Schedule of EirGen Purchase Price Allocation (Details) - USD ($)
$ in Thousands
Dec. 31, 2016
Dec. 31, 2015
May 31, 2015
Dec. 31, 2014
Business Acquisition [Line Items]        
Goodwill $ 704,603 $ 743,348   $ 224,292
EirGen Pharma Limited        
Business Acquisition [Line Items]        
Current assets     $ 11,795  
Intangible assets     38,634  
Goodwill     83,373  
Property, plant and equipment     8,117  
Other assets     1,232  
Accounts payable and other liabilities     (6,254)  
Deferred tax liability     (3,131)  
Total purchase price     133,766  
Cash and cash equivalents     5,500  
Accounts receivable     2,700  
Inventory     2,200  
Other current assets     1,400  
IPR&D assets | EirGen Pharma Limited        
Business Acquisition [Line Items]        
Intangible assets     560  
Customer relationships | EirGen Pharma Limited        
Business Acquisition [Line Items]        
Intangible assets     34,155  
Currently marketed products | EirGen Pharma Limited        
Business Acquisition [Line Items]        
Intangible assets     $ 3,919